Tag Archives: Kimberly Hedlin

Canaccord Genuity Reaffirms Their Buy Rating on Khiron Life Sciences (KHRNF)

Canaccord Genuity analyst Kimberly Hedlin maintained a Buy rating on Khiron Life Sciences (KHRNF – Research Report) yesterday and set a price target of C$2.80. The company’s shares closed last Monday at $0.55. According to TipRanks.com, Hedlin is a 4-star

Canaccord Genuity Reiterates Their Buy Rating on Khiron Life Sciences (KHRNF)

Canaccord Genuity analyst Kimberly Hedlin reiterated a Buy rating on Khiron Life Sciences (KHRNF – Research Report) today and set a price target of C$2.80. The company’s shares closed last Thursday at $0.60. According to TipRanks.com, Hedlin is a 4-star

Rubicon Organics (ROMJF) Gets a Buy Rating from Canaccord Genuity

In a report released today, Kimberly Hedlin from Canaccord Genuity maintained a Buy rating on Rubicon Organics (ROMJF – Research Report), with a price target of C$3.50. The company’s shares closed last Thursday at $1.83. According to TipRanks.com, Hedlin is

Canaccord Genuity Sticks to Its Hold Rating for Decibel Cannabis Company (DBCCF)

Canaccord Genuity analyst Kimberly Hedlin maintained a Hold rating on Decibel Cannabis Company (DBCCF – Research Report) today and set a price target of C$0.15. The company’s shares closed last Friday at $0.09, close to its 52-week low of $0.03.

Delta 9 Cannabis (VRNDF) Receives a Hold from Canaccord Genuity

Canaccord Genuity analyst Kimberly Hedlin maintained a Hold rating on Delta 9 Cannabis (VRNDF – Research Report) on May 15 and set a price target of C$0.60. The company’s shares closed last Friday at $0.34, close to its 52-week low

Canaccord Genuity Reiterates a Buy Rating on Khiron Life Sciences (KHRNF)

In a report released today, Kimberly Hedlin from Canaccord Genuity reiterated a Buy rating on Khiron Life Sciences (KHRNF – Research Report), with a price target of C$3.00. The company’s shares closed last Friday at $0.49, close to its 52-week